Remove Bioavailability Remove Contamination Remove Contract Manufacturing Remove Production
article thumbnail

Small molecule API: Shining a spotlight on new innovations in milling

Pharmaceutical Technology

The ingredients used in these drugs are high potency, even at small doses, and pose a risk to both human health and cross-contamination with other drugs in a manufacturing environment. Once set up and validated, the control process must guarantee constancy during production so that the results are as expected.

article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

According to GlobalData’s Drugs database, 97% of marketed drugs are small molecule products and analysis shows an increased CMO appetite for specialized capabilities, with controlled substance and containment facilities highly sought after [i].